Role of carnitine and its derivatives in the development and management of type 2 diabetes

J. Bene, Kinga Hadzsiev, Bela Melegh

Research output: Contribution to journalReview article

21 Citations (Scopus)


Type 2 diabetes is a highly prevalent chronic metabolic disorder characterized by hyperglycemia and associated with several complications such as retinopathy, hyperlipidemia and polyneuropathy. The dysregulated fatty acid metabolism along with tissue lipid accumulation is generally assumed to be associated in the development of insulin resistance and T2D. Moreover, several studies suggest a central role for oxidative stress in the pathogenesis of the disease. Since L-carnitine (LC) has an indispensable role in lipid metabolism via its involvement in the β-oxidation of long-chain fatty acids and it has antioxidant properties as well, carnitine supplementation may prove to be an effective tool in the management of the clinical course of T2D. In this review we summarize the results from animal and clinical studies demonstrating the effects of supplementation with LC or LC derivatives (acetyl-LC, propionyl-LC) on various metabolic and clinical parameters associated with T2D.

Original languageEnglish
Article number8
JournalNutrition and Diabetes
Issue number1
Publication statusPublished - Dec 1 2018

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Role of carnitine and its derivatives in the development and management of type 2 diabetes'. Together they form a unique fingerprint.

  • Cite this